Page last updated: 2024-11-07

2-acetylaminofluorene and Deficiency, Vitamin D

2-acetylaminofluorene has been researched along with Deficiency, Vitamin D in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, RK1
Gascon-Barré, M1

Other Studies

1 other study available for 2-acetylaminofluorene and Deficiency, Vitamin D

ArticleYear
Influence of the vitamin D status on the early hepatic response to carcinogen exposure in rats.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 281, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Calcium; Liver Neoplasms; Male; Precancerous Conditions; Rats; Rats,

1997